Motomu Hashimoto

46PUBLICATIONS
145CO-AUTHORS
PharmacogenomicsAutoimmunityRespiratory diseasesPodiatryClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Oct 28, 2026
Comparative effectiveness and safety of five Janus kinase inhibitors in real-world clinical practice: the multicentre ANSWER cohort.

|Oct 16, 2026
CD40-CD40L interactions in systemic autoimmune diseases.

|Sep 28, 2026
Renal function-adjusted initial JAK inhibitor dosing and outcomes in rheumatoid arthritis: from the ANSWER cohort study.

|Jun 19, 2026
Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort study.

|Apr 01, 2026
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort.

Yuki Etani, Yasutaka Okita, Kohei Tsujimoto

|Dec 12, 2025
Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: A multicentre REVEAL cohort study.

Hirofumi Miyake, Ayana Okazaki, Shogo Matsuda

Pageof 8

Frequent Collaborators

19 joint publications

Wataru Yamamoto

19 joint publications

Koichi Murata

17 joint publications

Akira Onishi

15 joint publications

Kosuke Ebina